About UBS Group AG Registered Ordinary Shares (UBS)
UBS Group AG is a global financial services company providing a wide range of financial services to clients, including wealth management, investment banking, and asset management. The firm caters to private, corporate, and institutional clients, delivering tailored financial solutions and expertise across various sectors and regions. UBS is known for its strong focus on sustainable finance and innovation, striving to create long-term value for its stakeholders while maintaining a commitment to corporate responsibility and ethical practices in the financial industry. Read More
Shares of professional staffing firm Kforce (NYSE:KFRC) fell 6.4% in the afternoon session after analysts revised their price targets and earnings forecasts downward for the professional staffing firm. UBS Group trimmed its price target on the professional staffing company, while William Blair cut its earnings per share estimates for both 2025 and 2026. These revisions followed the company's recent second-quarter report, where it posted a 6.2% year-over-year sales decrease and provided disappointing revenue guidance. This weak outlook from Kforce arrived amid broader economic concerns, as a surprisingly weak U.S. jobs report signaled a cooling labor market, which often reduced corporate spending on staffing services.
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 20.3% in the afternoon session after the company reported mixed second-quarter results where rising medical costs and a wider-than-expected loss overshadowed strong revenue growth. The technology-focused insurer announced revenue of $477.6 million, which climbed past analyst forecasts, fueled by a 32% jump in Medicare Advantage membership. However, the company posted a net loss of $0.02 per share, a reversal from a profit in the same quarter last year and a miss on analyst expectations. Investors focused on the increase in the Insurance Benefits Expense Ratio (BER), a key metric showing the portion of premiums spent on medical care, which rose to 88.4%. Compounding the issue, Clover Health also raised its forecast for the full-year BER, signaling that these higher costs would likely persist. In response to the report, analysts at UBS cut their price target on the stock.
UBS Global Wealth Management US has appointed two new Market Directors in the San Diego region, reflecting UBS’s continued investment in leadership, client relationships, and advisor growth in the Southern California market.
UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the “ETNs”).
Shares of tech giant Microsoft (NASDAQ:MSFT) jumped 2.6% in the afternoon session after investor optimism continued as the company received a series of analyst price target upgrades.
Shares of luxury fashion conglomerate Tapestry (NYSE:TPR)
jumped 3.6% in the afternoon session after the company completed the sale of its Stuart Weitzman brand, a strategic move that coincided with a broader market rally in consumer stocks. The divestment allowed Tapestry to concentrate its resources on its core Coach and Kate Spade brands. This corporate news was bolstered by a favorable economic backdrop, as weak U.S. jobs data fueled investor hopes for a potential interest rate cut by the Federal Reserve. The prospect of lower borrowing costs typically encouraged consumer spending, which benefited companies like Tapestry. Adding to the positive momentum, a UBS analyst maintained a neutral stance but significantly raised the price target on the stock.
In the 2017 agreement, Credit Suisse agreed to pay $5.7 billion as settlement fees for hiding the actual value of mortgage-backed securities ahead of the 2008 financial crisis.
Shares of outerwear manufacturer Columbia Sportswear (NASDAQ:COLM)
fell 14.6% in the morning session after the company issued a disappointing financial forecast for its third quarter and the full year, which overshadowed a second-quarter earnings beat.
Shares of real estate technology company Compass (NYSE:COMP) jumped 10.2% in the afternoon session after the company reported record-breaking financial results for its second quarter, outperforming a declining real estate market. The real estate technology company announced its GAAP Net Income grew by 90.3% year-over-year to a record $39.4 million. Compass also expanded its market share to a new high of 6.09%, attracting a record 832 principal agents during the quarter. The company's total transactions surged by 20.9%, a stark contrast to the wider market, which experienced a 0.9% contraction. This performance was underpinned by a 21.1% rise in revenue to $2.06 billion. Following the strong report, a UBS analyst raised the price target on the stock, reflecting renewed confidence.
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY)
fell 4.2% in the afternoon session after the company lowered its full-year earnings forecast, overshadowing second-quarter results that beat revenue expectations. The drugmaker trimmed its adjusted earnings per share guidance for 2025, attributing the cut to a $0.57 per share charge from a partnership with BioNTech. This charge also hit second-quarter net income, which fell compared to the prior year. Beyond the one-time charge, the company's results revealed underlying weakness, as sales from its older drugs declined 14% due to generic competition. Specifically, revenue from the cancer drug Revlimid plunged 38% year-over-year. Even though Bristol-Myers raised its annual sales forecast, the reduced profit outlook appeared to sour investor sentiment.
Shares of freight delivery company Landstar (NASDAQ:LSTR)
fell 3.3% in the morning session after the company reported second-quarter financial results that revealed a significant drop in year-over-year profitability, leading to several analyst price target cuts.
Shares of online marketplace Etsy (NASDAQ:ETSY)
jumped 5.5% in the morning session after the company reported second-quarter financial results that showed revenue growth despite a drop in gross merchandise sales.
